Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sari Jokinen"'
Publikováno v:
The Journal of Infectious Diseases. 197:950-956
Background The persistence of antibodies against measles, mumps, and rubella induced by the measles-mumps-rubella (MMR) vaccine and the kinetics of antibody decline after the second MMR vaccine dose were studied in the same cohort for 20 years. Metho
Publikováno v:
The Journal of Infectious Diseases. 191:719-723
The possible viral etiology of mumps-like illnesses in patients vaccinated for measles, mumps, and rubella (MMR) was studied by use of serum samples prospectively collected, during 1983-1998, from 601 acutely ill Finnish children and adolescents with
Autor:
Mira Kojouharova, R. Vranckx, P Teocharov, Nina Gatcheva, K Roubalova, Guido François, B. Kriz, Wiebke Hellenbrand, Robin Gopal, W. Thierfelder, Richard Pebody, I Klavs, T Kortbeek, Katarina Prosenc, Nick Andrews, Sari Jokinen, H.E. de Melker, P. Van Damme, David Brown, M. Valle
Publikováno v:
Sexually transmitted infections
Objectives: To describe the seroepidemiology of herpes simplex virus (HSV) types 1 and 2 in the general populations of eight European countries to better understand recent reported changes in disease epidemiology. Methods: Belgium, Bulgaria, Czech Re
Autor:
Sari Jokinen, Pauli Leinikki, Mikko Paunio, Martti Valle, Irja Davidkin, Tapani Hovi, Kimmo Linnavuori, Heikki Peltola, Merja Roivainen
Publikováno v:
The Journal of Infectious Diseases. 178:1567-1570
The viral etiology of measles- or rubella-like illnesses after MMR (measles, mumps, and rubella) vaccination was studied prospectively in 993 acutely ill Finnish children with fever and rash in 1983-1995. Their sera were tested for adeno-, entero-, a
Publikováno v:
The Journal of infectious diseases. 206(10)
Background The measles-mumps-rubella (MMR) vaccine is effective in eliciting a good antibody response. In addition to the amount of antibodies, the avidity of these antibodies might be important in protecting against disease. Methods The amount of ci
Autor:
Mia Kontio, Sari Jokinen, Anna Stalevskaya, Sergey Mukomolov, Irja Davidkin, Nina Zheleznova, Eugenia Sinayskaya
Publikováno v:
Journal of medical virology. 84(10)
The current study, covering the period 2004–2009, is a part of long-term monitoring for hepatitis A virus (HAV) strains circulating in St Petersburg, Russia. The HAV RNA was isolated directly from the sera of hepatitis A patients and RT-PCR was car
Autor:
Maija Lappalainen, Merja Roivainen, Kirsi Liitsola, Markku Kuusi, Irja Davidkin, Sari Jokinen, Mia Broman
Publikováno v:
Journal of medical virology. 82(6)
The seroepidemiology of hepatitis A virus (HAV) for the period 1990–2007 and the molecular epidemiology for the period 1994–2007 in Finland were studied. The incidence of hepatitis A has been very low since 1990, at 0.3–3.6/100,000 inhabitants,
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 125(14)
We investigated the health status, functional ability, mood and quality of life of 464 persons undergoing a rehabilitation period in two centers for care and rehabilition for war veterans' by comprehensive interviews and measurements of functional ab
Publikováno v:
The Lancet. Infectious diseases. 8(12)
A nationwide programme to eliminate indigenous measles, mumps, and rubella, mainly by vaccinating children twice, was launched in Finland in 1982. Strong scientific methods to examine the immunological, clinical, and epidemiological variables have ac
Publikováno v:
Journal of medical virology. 79(6)
The molecular epidemiology of hepatitis A virus (HAV) strains circulating in the St. Petersburg and Karelia regions was studied during 1997-2003. Hepatitis A virus RNA was isolated from both clinical samples (stools or sera) and environmental samples